NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 2026-10-31 20:55இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Q2FY27 PAT Drops 84% QoQ to ₹3.23 Cr Despite 116% YoY Revenue Jump
DMCC Speciality Chemicals reported its Q2FY27 results showing Revenue from Operations of ₹272.88 Cr, up 116.51% YoY and 7.85% QoQ. However, profitability contracted severely due to elevated sulphur input costs that could not be passed on to sulphuric acid pricing. EBITDA plunged 66.26% QoQ to ₹11.62 Cr with margins compressing 934 bps QoQ to 4.25%. Consequently, Profit After Tax plummeted 84.18% QoQ and 43.88% YoY to ₹3.23 Cr.
உச்சம் நம்பிக்கை
என்ன மாறியதுSevere margin squeeze in Q2FY27 caused by a sharp divergence between elevated raw material (sulphur) costs and finished goods (sulphuric acid) prices.
ஏன் இது முக்கியம்High exposure to commodity bulk chemicals (73% of sales) leaves DMCC vulnerable to price mismatches, significantly impairing operating cash flows and spiking short-term borrowing needs.
Revenue from Operations: ₹ 272.88 CrEBITDA லாப வரம்பு: 4.25%Profit After Tax: ₹ 3.23 CrBulk vs Speciality mix: 73% / 27%Quarterly PAT vs TTM PAT (₹40 Cr): ~8.1%
📅 குறுகிய காலம்Margin recovery will depend on whether the post mid-October cooling in sulphur prices sustains and allows capacity ramp-ups without price undercutting.
📈 நீண்ட காலம்Structural margins depend on increasing the share of Boron and higher-margin speciality chemicals above the current 27% to reduce commodity cycle exposure.
⚠ அபாய எச்சரிக்கைகள்
Inability to pass on raw material price increases in bulk chemicals
Rising debt and finance costs (interest cost rose 100.7% YoY to ₹3.83 Cr)
Macro and geopolitical uncertainty impacting raw material supply
👀 கவனிக்க வேண்டியவை
Track the trajectory of global sulphur prices and sulphuric acid realizations in Q3FY27, alongside management's commentary on plant operating rates and working capital debt levels.
DMCC Speciality Chemicals approved its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. Consolidated total assets expanded to Rs 494.90 crore (Rs 49,490.54 lakhs) compared to Rs 445.51 crore as of March 31, 2026. Standalone trade receivables rose significantly to Rs 145.53 crore from Rs 95.95 crore at the end of FY26. For H1 FY27, net cash inflow from financing activities stood at Rs 2.48 crore, while net cash used in investing activities was Rs 5.93 crore.
உச்சம் நம்பிக்கை
என்ன மாறியதுDMCC reported its balance sheet and cash flows for the half-year ended September 30, 2026, showing an expansion in assets and short-term debt.
ஏன் இது முக்கியம்Demonstrates balance sheet movements, including a rise in short-term borrowings to Rs 66.52 crore from Rs 49.62 crore to fund rising working capital requirements.
Consolidated Total Assets: Rs 49,490.54 lakhsவர்த்தக வசூலிக்கவேண்டியவை: Rs 14,553.48 lakhsShort-term Borrowings: Rs 6,652.34 lakhsConsolidated Net Worth: Rs 26,506.02 lakhs
📅 குறுகிய காலம்Market response is expected to be neutral given the administrative disclosure excerpt without major unexpected shocks, though working capital stretch will be evaluated.
📈 நீண்ட காலம்Performance will hinge on the company's margin defense against raw material volatility (benzene/sulfur) and capacity utilization of higher-margin specialty products.
⚠ அபாய எச்சரிக்கைகள்
Significant increase in trade receivables from Rs 95.94 cr to Rs 145.53 cr indicates potential working capital elongation
Higher short-term borrowings rising to Rs 66.52 cr from Rs 49.62 cr
👀 கவனிக்க வேண்டியவை
Monitor working capital efficiency in the coming quarters, particularly the collection cycle given the notable rise in trade receivables to Rs 145.53 crore.
163% PAT Growth in Q1FY27; Revenue Surges to Rs 253 Cr on Inventory Gains
DMCC reported a sharp 99% YoY revenue growth to Rs 253.01 Cr for Q1FY27, with PAT jumping 163% to Rs 20.40 Cr. Management has explicitly cautioned that these results are 'optically strong' due to significant inventory gains from rising sulphur prices and are not structurally sustainable. The pricing environment has stretched working capital, leading to higher receivables, inventory balances, and a 72% YoY increase in interest costs from short-term borrowings. Despite global supply disruptions in the Strait of Hormuz, the company maintained full operational continuity at its Dahej and Roha plants.
உச்சம் நம்பிக்கை
என்ன மாறியதுDMCC delivered a record quarterly performance in Q1FY27, nearly doubling its revenue YoY, primarily driven by a significant escalation in sulphur and sulfuric acid prices rather than structural volume expansion.
ஏன் இது முக்கியம்The results highlight the company's ability to pass on cost increases and maintain supply during global disruptions, but the reliance on inventory gains suggests the current profitability level is temporary and has led to a stretched balance sheet.
📅 குறுகிய காலம்The stock may see positive momentum from the headline growth, but the management's warning about non-sustainable inventory gains and stretched working capital may lead to volatility.
📈 நீண்ட காலம்The structural strength depends on the company's transition toward specialty chemicals and geographic diversification; the current quarter is an outlier due to commodity price spikes.
⚠ அபாய எச்சரிக்கைகள்
Inventory gain reversal risk
Stretched working capital
Increased short-term debt
Raw material price volatility (Sulphur)
👀 கவனிக்க வேண்டியவை
Investors should monitor the trajectory of global sulphur prices, as management expects inventory gains to reverse and profits to normalize as prices moderate. Key metrics to watch in the next quarter include the reduction in working capital intensity and the stability of margins without one-off pricing benefits.
Rs 2.5 Divid e n d: DM C C S e t s A u g u s t 2 1, 2 0 2 6, a s R e c o r d D a t e
DM C C S p e c i a l i t y C h e m i c a l s h a s f i x e d A u g u s t 2 1, 2 0 2 6, a s t h e r e c o r d d a t e f o r i t s r e c o m m e n d e d f i n a l d i v i d e n d o f R s 2.5 p e r e q u i t y s h a r e (2 5% o f f a c e v a l u e). T h e d i v i d e n d i s s u b j e c t t o s h a r e h o l d e r a p p r o v a l a t t h e u p c o m i n g A G M o n S e p t e m b e r 1 1, 2 0 2 6. B a s e d o n t h e c u r r e n t p r i c e o f R s 2 8 8, t h i s r e p r e s e n t s a d i v i d e n d y i e l d o f a p p r o x i m a t e l y 0.8 7%. T h e c o m p a n y r e p o r t e d a T T M P A T o f R s 2 7 c r o r e f o r F Y 2 6.
hig h நம்பிக்கை
என்ன மாறியதுThe c o m p a n y h a s f o r m a l i z e d t h e t i m e l i n e f o r i t s p r e v i o u s l y r e c o m m e n d e d d i v i d e n d p a y m e n t f o r t h e f i n a n c i a l y e a r.
ஏன் இது முக்கியம்This i s a r o u t i n e d i s t r i b u t i o n o f p r o f i t s t o s h a r e h o l d e r s, r e f l e c t i n g t h e c o m p a n y's a b i l i t y t o g e n e r a t e c a s h f l o w f r o m i t s R s 5 8 2 c r o r e T T M r e v e n u e b a s e.
Divid e n d p e r s h a r e: Rs 2.5Divid e n d y i e l d: 0.8 7%Recor d D a t e: 2 1-A u g-2 0 2 6AG M D a t e: 1 1-S e p-2 0 2 6Face V a l u e: Rs 1 0
📅 குறுகிய காலம்The s t o c k m a y e x p e r i e n c e a m i n o r p r i c e a d j u s t m e n t o n t h e e x-d i v i d e n d d a t e, t y p i c a l l y o n e b u s i n e s s d a y p r i o r t o t h e r e c o r d d a t e.
📈 நீண்ட காலம்Limit e d; t h i s i s a p r o c e d u r a l a n n o u n c e m e n t r e l a t e d t o p a s t p e r f o r m a n c e r a t h e r t h a n f u t u r e g r o w t h c a p a b i l i t y.
⚠ அபாய எச்சரிக்கைகள்
None m a t e r i a l
👀 கவனிக்க வேண்டியவை
Ensur e s h a r e s a r e h e l d i n t h e d e m a t a c c o u n t b y t h e r e c o r d d a t e (A u g 2 1) t o b e e l i g i b l e f o r t h e p a y o u t; p h y s i c a l s h a r e h o l d e r s m u s t u p d a t e K Y C d e t a i l s t o a v o i d w i t h h e l d p a y m e n t s.
DMCC Speciality Chemicals reported a robust performance for Q1 FY27, with consolidated revenue surging 99% YoY to Rs 253.01 Cr from Rs 127.04 Cr. Net profit for the quarter jumped 163% YoY to Rs 20.40 Cr, compared to Rs 7.76 Cr in the year-ago period. The quarterly EPS of Rs 8.18 is a significant improvement over the Rs 3.11 reported in Q1 FY26 and represents a substantial portion of the total FY26 EPS (Rs 10.96). This growth indicates a successful scale-up of operations, although raw material costs have also risen to Rs 196.99 Cr.
உச்சம் நம்பிக்கை
என்ன மாறியதுDMCC has significantly scaled its quarterly operations, moving from a historical revenue range of Rs 125-175 Cr to over Rs 250 Cr in Q1 FY27.
ஏன் இது முக்கியம்The sharp increase in profitability suggests that the company's previously 'enhanced capacities' are now being utilized effectively, potentially leading to a structural shift in its earnings profile.
📅 குறுகிய காலம்The stock is likely to react positively in the short term due to the significant YoY and QoQ growth in both revenue and net profit.
📈 நீண்ட காலம்If DMCC sustains this quarterly performance, it could significantly outpace its FY26 annual revenue of Rs 581 Cr, marking a major growth phase for the company.
⚠ அபாய எச்சரிக்கைகள்
High raw material cost sensitivity (78% of revenue)
Limited pricing power in bulk chemical segments
Volatility in global sulfur and benzene prices
👀 கவனிக்க வேண்டியவை
Investors should monitor the sustainability of this higher revenue run-rate in upcoming quarters and track whether the company can maintain margins despite high raw material cost sensitivity.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
DMCC Q4FY26 Revenue Jumps 42% YoY to ₹177.6 Cr; PAT Grows 18% Amid Supply Chain Hurdles
DMCC Speciality Chemicals reported a strong 41.87% YoY revenue growth in Q4FY26, reaching ₹177.64 crore, primarily driven by higher realizations in sulphuric acid following a spike in global sulphur prices. Despite geopolitical tensions in the Middle East causing raw material shortages at the Roha site, the company successfully passed on costs to maintain absolute profitability, with PAT rising 18.27% YoY to ₹7.65 crore. However, higher input costs have stretched working capital requirements, leading to increased short-term borrowings and a 53.75% YoY rise in interest costs. While the speciality chemicals segment shows early signs of recovery in overseas markets, management remains cautious due to ongoing global supply chain volatility.
முக்கிய அம்சங்கள்
Revenue for Q4FY26 grew 41.87% YoY to ₹177.64 crore, while full-year FY26 revenue rose 34.84% to ₹581.58 crore.Net Profit (PAT) for the quarter increased by 18.27% YoY to ₹7.65 crore, with FY26 PAT growing 26.95% to ₹27.33 crore.EBITDA margins for Q4 stood at 10.05%, improving 179 bps sequentially but declining from 12.39% in the previous year's quarter.Speciality chemicals contributed 31% of revenue, with management noting an encouraging uptick in inquiry flow from overseas markets.Interest costs rose significantly by 53.75% YoY to ₹3.37 crore in Q4, reflecting the impact of short-term borrowings for working capital.
👀 கவனிக்க வேண்டியவை
Investors should monitor the company's ability to manage working capital and interest costs as supply chains stabilize. The recovery in the speciality chemicals segment and the company's success in passing on raw material hikes are positive indicators for medium-term growth.
DMCC Speciality Chemicals FY26 Net Profit Rises 27% to ₹27.3 Cr; Declares ₹2.50 Dividend
DMCC Speciality Chemicals reported a strong performance for FY26, with consolidated revenue growing 34.8% year-on-year to ₹581.6 crore. Net profit for the full year increased by 26.9% to ₹27.3 crore, supported by robust sales in the chemical manufacturing segment. The board has recommended a final dividend of ₹2.50 per share (25% of face value). However, investors should note a significant increase in short-term borrowings to ₹49.6 crore, which appears to be linked to a doubling of inventory levels to ₹91.9 crore.
முக்கிய அம்சங்கள்
Consolidated FY26 revenue increased by 34.8% YoY to ₹581.58 crore.Annual consolidated net profit grew by 26.9% to ₹27.33 crore from ₹21.53 crore in FY25.Board recommended a final dividend of 25% (₹2.50 per equity share of ₹10 face value).Inventory levels surged to ₹91.89 crore from ₹42.59 crore, contributing to higher short-term debt of ₹49.62 crore.Full-year Consolidated Earnings Per Share (EPS) improved to ₹10.96 from ₹8.63.
👀 கவனிக்க வேண்டியவை
The company shows strong operational growth and maintains a healthy dividend payout; however, monitor the rising working capital and debt levels in future quarters. Long-term investors may find the growth trajectory in the speciality chemicals segment encouraging.
DMCC Shareholders Approve MD & CEO Re-appointment and MoA/AoA Changes with 99.99% Majority
DMCC Speciality Chemicals has successfully passed five key resolutions via postal ballot, all receiving over 99.99% shareholder support. A major outcome is the re-appointment of Bimal Lalitsingh Goculdas as MD and CEO for a three-year term effective April 1, 2026. Shareholders also approved the appointment of Saloni Jhaveri as an Independent Director and a salary revision for Executive Director Kuldeep Kumar Tiwari. Furthermore, the company received approval to modernize its Memorandum and Articles of Association, ensuring updated corporate governance frameworks.
முக்கிய அம்சங்கள்
Bimal Lalitsingh Goculdas re-appointed as MD & CEO for a 3-year term from April 2026 to March 2029.All five resolutions passed with an overwhelming majority of approximately 99.99% of votes cast.Shareholders approved the appointment of Saloni Jhaveri as an Independent Director.The company received authorization to alter its Memorandum and adopt new Articles of Association.A total of 13,039,108 votes were polled, accounting for 52.28% of the total shareholding.
👀 கவனிக்க வேண்டியவை
The strong shareholder support for leadership continuity and governance updates is a positive indicator of stability. Investors should remain confident in the current management's strategic direction for the upcoming 2026-2029 period.
DMCC Seeks Shareholder Approval for MD Re-appointment and Board Changes
DMCC Speciality Chemicals has initiated a postal ballot to seek shareholder approval for the re-appointment of Bimal Lalitsingh Goculdas as MD & CEO for a three-year term effective April 1, 2026. The company is also proposing the appointment of Saloni Jhaveri as a Women Independent Director for a five-year term and a revision in the remuneration of Executive Director Kuldeep Kumar Tiwari. Additionally, resolutions include the alteration of the Memorandum of Association and adoption of new Articles of Association. The e-voting process concludes on March 15, 2026, with results expected by March 17, 2026.
முக்கிய அம்சங்கள்
Re-appointment of Bimal Lalitsingh Goculdas as MD & CEO for a 3-year term (2026-2029)Appointment of Saloni Jhaveri as Women Independent Director for a 5-year term starting January 2026Revision of remuneration for Kuldeep Kumar Tiwari, Executive Director (Operations), effective April 1, 2026Proposed updates to the Memorandum of Association (MoA) and Articles of Association (AoA)E-voting period scheduled from February 13, 2026, to March 15, 2026
👀 கவனிக்க வேண்டியவை
Investors should support the resolutions to ensure leadership continuity, while keeping an eye on the specific details of the remuneration revision in the full explanatory statement.
DMCC Q3FY26 Revenue Up 28% YoY to ₹151 Cr; PAT Declines 22% on Margin Pressure
DMCC reported a strong 27.81% YoY growth in revenue to ₹150.87 crore for Q3FY26, driven by the resumption of the Boron business and improved realisations. However, EBITDA margins contracted significantly by 543 bps to 9.87% as elevated sulphur costs and a higher revenue base impacted percentages. While quarterly PAT fell 21.64% YoY to ₹6.17 crore, the 9-month performance remains robust with 9MFY26 PAT up 30.68% at ₹19.67 crore. The company expects the Boron segment to contribute ₹125-150 crore in annual revenue moving forward.
முக்கிய அம்சங்கள்
Revenue from operations grew 27.81% YoY to ₹150.87 crore in Q3FY26.EBITDA margins compressed by 543 bps YoY to 9.87% due to high raw material costs and pricing divergence.Resumed Boron operations are projected to generate ₹125-150 crore in annual revenue.9MFY26 PAT increased by 30.68% to ₹19.67 crore compared to ₹15.06 crore in 9MFY25.Sustainability initiatives now contribute over 80% of the company's energy requirements through solar and waste heat recovery.
👀 கவனிக்க வேண்டியவை
Investors should monitor the stabilization of margins as the company navigates volatile sulphur prices and the full-scale ramp-up of the Boron business. The strong 9-month cumulative growth suggests underlying resilience despite the quarterly margin hit.
DMCC Re-appoints Bimal Goculdas as MD & CEO for 3 Years; Approves Q3 FY26 Results
DMCC Speciality Chemicals has approved the re-appointment of Bimal Lalitsingh Goculdas as Managing Director and CEO for a three-year term starting April 2026. The board also approved an increase in remuneration for Executive Director Kuldeep Kumar Tiwari and proposed significant updates to the company's Memorandum and Articles of Association to align with the Companies Act 2013. While the Q3 FY26 financial results were approved, the specific P&L figures were not detailed in the provided cover letter, though the auditor's review report was clean. These changes aim to provide better operational flexibility and governance alignment for the company.
முக்கிய அம்சங்கள்
Re-appointment of Bimal Lalitsingh Goculdas as MD & CEO for a 3-year term from April 1, 2026, to March 31, 2029.Proposed increase in remuneration for Shri Kuldeep Kumar Tiwari, Executive Director (Operations), subject to postal ballot approval.Comprehensive update of Memorandum of Association (MOA) and Articles of Association (AOA) to align with the Companies Act 2013.Approval of Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2025.The board meeting commenced at 1:00 p.m. and concluded at 3:05 p.m. on February 6, 2026.
👀 கவனிக்க வேண்டியவை
Investors should view the leadership continuity as a sign of stability for the company's long-term strategy. Monitor the upcoming Postal Ballot results and the detailed Q3 financial performance once fully released to assess operational growth.
DMCC: Sonal Naik Resigns as Company Secretary & Compliance Officer
DMCC Speciality Chemicals Limited announced the resignation of Ms. Sonal Naik from the position of Company Secretary & Compliance Officer, effective December 16, 2025. Ms. Naik is leaving to explore opportunities outside the organization. Consequently, she will also cease to be a Key Managerial Personnel as per Section 203 of the Companies Act, 2013. The company is in the process of finding a suitable replacement.
முக்கிய அம்சங்கள்
Ms. Sonal Naik resigned as Company Secretary & Compliance Officer.Resignation effective from close of business hours on December 16, 2025.Ms. Naik will cease to be Key Managerial Personnel on December 16, 2025.ICSI Membership No. of Sonal Naik is ACS 43179.
👀 கவனிக்க வேண்டியவை
Investors should monitor the appointment of the new Company Secretary & Compliance Officer. This change is part of normal business operations.
DMCC: Supreme Court rules in favor regarding 52-acre land
DMCC Speciality Chemicals has announced that the Supreme Court of India ruled in its favor regarding a civil appeal. The appeal concerned a 52-acre piece of land in Nalimbi, near Ambernath, Taluka, Kalyan, which the government of Maharashtra had previously designated as Forest Land under The Maharashtra Private Forest (Acquisition) Act, 1975. The Supreme Court's decision quashes the previous orders and declarations, directing corrections in revenue records. DMCC will now take necessary steps as advised, potentially unlocking value from this land.
முக்கிய அம்சங்கள்
Company owns 52 acres of land at village NalimbiLand was acquired under The Maharashtra Private Forest (Acquisition) Act, 1975Civil appeal was filed before Supreme Court of India (SCI)Supreme Court quashed orders treating land as 'Forest Land'
👀 கவனிக்க வேண்டியவை
Investors should monitor DMCC's actions regarding the 52-acre land and any potential impact on the company's financials. This ruling could positively affect the company's asset value.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
